研究成果・実績

Subjective well-being and month-long LF/HF ratio among deskworkers.

Shiga K, Izumi K, Minato K, Sugio T, Yoshimura M, Kitazawa M, Hanashiro S, Cortright K, Kurokawa S, Momota Y, Sado M, Maeno T, Takebayashi T, Mimura M, Kishimoto T. PLoS One. 2021 Sep 7;16(9):e0257062.

What Can We Tell About the Effect of Electroconvulsive Therapy on the Human Hippocampus?

Takamiya A, Kishimoto T, Mimura M. Clin EEG Neurosci. 2021 Sep 21:15500594211044066.

Gastrointestinal symptoms and sensory abnormalities associated with behavioral problems in children with neurodevelopmental disorders.

Kurokawa S, Nomura K, Miyaho K, Sanada K, Iwamoto C, Naraoka M, Yoneda S, Tomizawa Y, Sawae Y, Iwanaga R, Mimura M, Kishimoto T. Autism Res. 2021 Sep;14(9):1996-2001.

Electroconvulsive Therapy for Patients With Depression Who Lack Capacity for Consent: Doing Good and Doing No Harm.

Takamiya A, Bouckaert F, Sienaert P, Uchida T, Kudo S, Yamagata B, Kishimoto T, Mimura M, Hirano J. J ECT. 2021 Sep 1;37(3):171-175.

Long-acting antipsychotics: is what we know really so? – Authors’ reply.

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Lancet Psychiatry. 2021 Aug;8(8):651-652.

Association of electroconvulsive therapy-induced structural plasticity with clinical remission.

Takamiya A, Kishimoto T, Hirano J, Kikuchi T, Yamagata B, Mimura M. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110286.

Long-acting injectable versus oral antipsychotics for schizophrenia – Authors’ reply.

Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Lancet Psychiatry. 2021 Jul;8(7):567.

Elevated body weight modulates subcortical volume change and associated clinical response following electroconvulsive therapy.

Opel N, Narr KL, Abbott C, Argyelan M, Espinoza R, Emsell L, Bouckaert F, Sienaert P, Vandenbulcke M, Nordanskog P, Repple J, Kavakbasi E, Jorgensen MB, Paulson OB,DMSc12; Lars G. Hanson, Dols A, van Exel E, Oudega ML, Takamiya A, Kishimoto T, Ousdal OT, Haavik J, Hammar Å, Oedegaard KJ, Kessler U, Bartsch H, Dale AM, Baune BT, Dannlowski U, Oltedal L, Redlich R. J Psychiatry Neurosci. 2021 Jul 5;46(4):E418-E426.

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

Numata S, Nakataki M, Hasegawa N, Takaesu Y, Takeshima M, Onitsuka T, Nakamura T, Edagawa R, Edo H, Miura K, Matsumoto J, Yasui-Furukori N, Kishimoto T, Hori H, Tsuboi T, Yasuda Y, Furihata R, Muraoka H, Ochi S, Nagasawa T, Kyou Y, Murata A, Katsumoto E, Ohi K, Hishimoto A, Inada K, Watanabe K, Hashimoto R. Neuropsychopharmacol Rep. 2021 Jun;41(2):199-206.

Fecal Microbial and Metabolomic Change during treatment course for depression: An Observational Study.

Kurokawa S, Tomizawa Y, Miyaho K, Ishii D, Takamiya A, Ishii C, Sanada K, Fukuda S, Mimura M, Kishimoto T. J Psychiatr Res. 2021 May 8;140:45-52.